Presentations in this session:

14:15 MOAA0201 Abstract Powerpoint (5.14 MB)	Probing the promiscuity of the HIV-1 neutralizing 2F5 antibody Presented by Jean-Philippe Julien, Canada J.-P. Julien, S. Bryson, E.F. Pai University of Toronto, Biochemistry, Toronto, Canada
14:30 MOAA0203 Abstract Powerpoint (1.53 MB)	The E2DISP antigen display system: a novel HIV vaccine approach Presented by Dina N Lauman, United States D.N. Lauman1, A. Caivano2, G. Domingo3, L. Meoli2, S. Thomas4, W.F. Sutton5, M.-K. Kaja4, N.L. Haigwood5, P. De Berardinis2, N. Doria-Rose5 1University of Washington, Molecular and Cellular Biology Program, Seattle, United States, 2National Research Council, Institute of Protein Biochemistry, Naples, Italy, 3Program for Appropriate Technology in Health (PATH), Seattle, United States, 4University of Washington, Department of Immunology, Seattle, United States, 5Seattle Biomedical Research Institute, Seattle, United States
14:45 MOAA0204 Abstract Powerpoint (969 KB)	Vaccine-relevant mimotopes selected with neutralizing IgG present in plasma from long-term non-progressors (LTNP) by phage display Presented by Ursula Dietrich, Germany M. Humbert1, S. Antoni1, M. Landersz1, B. Rodes2, V. Soriano2, H. Knechten3, S. Staszewski4, D. von Laer1, M. Dittmar5, U. Dietrich1 1Georg-Speyer-Haus, Molecular Virology, Frankfurt, Germany, 2Instituto de Salud Carlos III, Madrid, Spain, 3Praxiszentrum Blondelstr., Aachen, Germany, 4JW Goethe University Hospital, Division of Infectious Diseases, Frankfurt, Germany, 5Hygiene Institute, Virology, Heidelberg, Germany
15:00 MOAA0205 Abstract Powerpoint (858 KB)	Maternal neutralizing antibodies to a CRF01_AE primary isolate are associated with low intra-partum transmission of HIV-1 in Thailand Presented by Tanawan Samleerat, Thailand T. Samleerat1, G. Jourdain2, M. Braibant3, N. Ngo-Giang-Huong2, M. Lallement2, P. Leechanachai4, S. Sirithadthamrong5, V. Surasaerneewongse6, B. Warachit7, S. Hotrawarikarn8, F. Barin3 1Université F Rabelais, Tours, France; Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand, 2Harvard University, IRD 054; Institut de Recherche pour le Développement, UMI 174, Chiang Mai, Thailand, 3Université F Rabelais, Tours, France, 4Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand, 5Banglamung Hospital, Chonburi, Thailand, 6Bhumibol Adulyadej Hospital, Bangkok, Thailand, 7Hat Yai Hospital, Songkla, Thailand, 8Klaeng Hospital, Rayong, Thailand
15:15 MOAA0206 Abstract Powerpoint (5.75 MB)	Loop deletions in gp120 expose the CD4 binding site for improved binding of 1b12 and F105 antibodies Presented by Ira Berkower, United States I. Berkower, Y. Ni, C. Patel, A. Spadaccini Center for Biologics, FDA, Division of Viral Products, Office of Vaccine Research, Bethesda, MD, United States